Proteazlar biotizimlarda hamma joyda mavjud bo'lib, ular hujayralar va organizmlarning biokimyoviy, fiziologik va tartibga solish jihatlarida turli XIL rollarga EGA

kukunsimon Veron® P , Veron® HPP , Veron® S 50 , va suyuqlik ko’rinishidagi Veron® L10.
Shuningdek, ishlab chiqarishda yuqorida ta’kidlab o’tilgan Veron® W preparatidan ham foydalanishimiz mumkin. Gemisellulozaning qo’llanilishi, masalan ksilanaza Veron® 393  orqali kamroq qattiqlikka ega bo’lgan xamir olish mumkin va retseptdagi suvning miqdori ham kamayadi. Xamirturush usulida kreker ishlab chiqarishda qo’ziqorin amilazasi, masalan, Veron® 2000 yoki Veron® M4 dan foydalangan ma’qulroq, chunki bu preparatlar oshirilgan xamirning tezroq yetilishi va tayyor mahsulotlar sifatini yaxshilashda juda muhim. Ksilanaza va transglutaminaza preparatlari kompleksi- Veron® HF suli pechenyesi ishlab chiqarishda foydalaniladi. Bu modda xamirni stabillashtirib turadi, tayyor mahsulotga yaxshi forma beradi, yuqoridagi fermentlarning kreker ishlab chiqarishda 100g unga nisbatan qo’llanilish dozasi: Veron® P - 100-500 g; Veron® L10 - 40-80 g; Veron® W - 60-200 g; Veron® HPP - 5-15 g; Veron® S 50 - 5-20g, Veron® 393 - 3-5 g, Veron® 2000 - 5-10 g, Veron® M4 - 0,2-1 g ,Veron® HF - 5-15g ni tashkil etadi. Preparatlar komponentlarni aralashtirish jarayonida solinadi.

References
1. Adams J., Palombella V.J., Sausville E.A. Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents. Cancer Res. 1999;59:2615–2622. [PubMed] [Google Scholar]
2. Dolly J.O., Aoki K.R. The Structure and Action of Different Botulinum Toxins. Eur. J. Neurol. 2006;13(Suppl. 4):1–9. [PubMed] [Google Scholar]
3. Fujinami S., Fugisawa M. Industrial Applications of Alkaliphiles and Their Enzymes – Past, Present and Future. Environ. Technol. 2010;31:845–857. [PubMed] [Google Scholar]
4. Harrington D.J. Bacterial Collagenases and Collagen-degrading Enzymes and Their Potential in Human Disease. Infect. Immun. 1996;64:1885–1891. [PMC free article] [PubMed] [Google Scholar]
5. Kuchner O., Arnold F.H. Directed Evolution of Enzyme Catalysts. TibTech. 1997;15:523–529. [Google Scholar]
6. Kumar C.G., Takegi H. Microbial Alkaline Proteases: From a Bioindustrial Viewpoint. Biotechnol. Adv. 1999;17:561–594. [PubMed] [Google Scholar]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151786/